| ■ 영문 제목 : Global Biopharmaceutical Analytical Testing Services Market 2023-2027
|
 | ■ 상품코드 : IRTNTR40457-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 1월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 아시아 태평양, 유럽, 남미, 중동 및 아프리카
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사는 세계의 바이오 의약품 분석 시험 서비스 시장 규모가 2022년부터 2027년 사이에 3,449.57백만 달러에 이르며, 예측 기간 동안 연평균 12.61% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 바이오 의약품 분석 시험 서비스 시장에 대해 조사 및 분석하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 서비스별 (생물 분석, 방법 개발 및 검증, 안정성 시험, 기타) 분석, 최종 용도별 (제약, 바이오 테크놀로지 기업, CRO), 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 중동 및 아프리카, 남미, 미국, 중국, 일본, 영국, 독일) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc와 같은 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・Five Force 분석
・세계의 바이오 의약품 분석 시험 서비스 시장 규모 : 서비스별
- 생물 분석 서비스의 시장 규모
- 방법 개발 및 검증 서비스의 시장 규모
- 안정성 시험 서비스의 시장 규모
- 기타 서비스의 시장 규모
・세계의 바이오 의약품 분석 시험 서비스 시장 규모 : 최종 용도별
- 제약에 사용되는 바이오 의약품 분석 시험 서비스의 시장 규모
- 바이오 테크놀로지 기업에서 사용되는 바이오 의약품 분석 시험 서비스의 시장 규모
- CRO에 사용되는 바이오 의약품 분석 시험 서비스의 시장 규모
・고객 현황
・지역별 현황
- 북미의 바이오 의약품 분석 시험 서비스 시장 규모
- 아시아 태평양의 바이오 의약품 분석 시험 서비스 시장 규모
- 유럽의 바이오 의약품 분석 시험 서비스 시장 규모
- 남미의 바이오 의약품 분석 시험 서비스 시장 규모
- 중동 및 아프리카의 바이오의약품 분석 시험 서비스 시장 규모
- 미국의 바이오 의약품 분석 시험 서비스 시장 규모
- 중국의 바이오 의약품 분석 시험 서비스 시장 규모
- 일본의 바이오 의약품 분석 시험 서비스 시장 규모
- 영국의 바이오 의약품 분석 시험 서비스 시장 규모
- 독일의 바이오 의약품 분석 시험 서비스 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 바이오 의약품 분석 시험 서비스 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 바이오 의약품 분석 시험 서비스 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Biopharmaceutical Analytical Testing Services Market 2023-2027Technavio has been monitoring the biopharmaceutical analytical testing services market and is forecast to grow by $3449.57 mn during 2022-2027, accelerating at a CAGR of 12.61% during the forecast period. Our report on the biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increase in demand for mAbs, an increase in the number of patent-expired drugs, and an increase in chronic diseases.
Technavio’s biopharmaceutical analytical testing services market is segmented as below:
By Service
• Bioanalytical
• Method development and validation
• Stability testing
• Others
By End-user
• Pharma
• biotech companies
• CROs
By Geographical Landscape
• North America
• APAC
• Europe
• South America
• Middle East and Africa
This study identifies the rise in investment in r and d as one of the prime reasons driving the biopharmaceutical analytical testing services market growth during the next few years. Also, the rise in the production of vaccines and increasing outsourcing of analytical testing services will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biopharmaceutical analytical testing services market covers the following areas:
• Biopharmaceutical analytical testing services market sizing
• Biopharmaceutical analytical testing services market forecast
• Biopharmaceutical analytical testing services market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biopharmaceutical analytical testing services market vendors that include Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc. Also, the biopharmaceutical analytical testing services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Service
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biopharmaceutical analytical testing services market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global biopharmaceutical analytical testing services market 2017 – 2021 ($ million)
o 4.2 Service Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Service Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Service
o 6.1 Market segments
o Exhibit 30: Chart on Service – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Service – Market share 2022-2027 (%)
o 6.2 Comparison by Service
o Exhibit 32: Chart on Comparison by Service
o Exhibit 33: Data Table on Comparison by Service
o 6.3 Bioanalytical – Market size and forecast 2022-2027
o Exhibit 34: Chart on Bioanalytical – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Bioanalytical – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Bioanalytical – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Bioanalytical – Year-over-year growth 2022-2027 (%)
o 6.4 Method development and validation – Market size and forecast 2022-2027
o Exhibit 38: Chart on Method development and validation – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Method development and validation – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Method development and validation – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Method development and validation – Year-over-year growth 2022-2027 (%)
o 6.5 Stability testing – Market size and forecast 2022-2027
o Exhibit 42: Chart on Stability testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Stability testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Stability testing – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Stability testing – Year-over-year growth 2022-2027 (%)
o 6.6 Others – Market size and forecast 2022-2027
o Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Service
o Exhibit 50: Market opportunity by Service ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 51: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 52: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 53: Chart on Comparison by End-user
o Exhibit 54: Data Table on Comparison by End-user
o 7.3 Pharma and biotech companies – Market size and forecast 2022-2027
o Exhibit 55: Chart on Pharma and biotech companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Pharma and biotech companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Pharma and biotech companies – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Pharma and biotech companies – Year-over-year growth 2022-2027 (%)
o 7.4 CROs – Market size and forecast 2022-2027
o Exhibit 59: Chart on CROs – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on CROs – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on CROs – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 63: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 APAC – Market size and forecast 2022-2027
o Exhibit 73: Chart on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on APAC – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on APAC – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 South America – Market size and forecast 2022-2027
o Exhibit 81: Chart on South America – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on South America – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on South America – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on South America – Year-over-year growth 2022-2027 (%)
o 9.7 Middle East and Africa – Market size and forecast 2022-2027
o Exhibit 85: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
o 9.8 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 101: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Germany – Market size and forecast 2022-2027
o Exhibit 105: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Almac Group Ltd.
o Exhibit 116: Almac Group Ltd. – Overview
o Exhibit 117: Almac Group Ltd. – Product / Service
o Exhibit 118: Almac Group Ltd. – Key offerings
o 12.4 Boston Analytical
o Exhibit 119: Boston Analytical – Overview
o Exhibit 120: Boston Analytical – Product / Service
o Exhibit 121: Boston Analytical – Key news
o Exhibit 122: Boston Analytical – Key offerings
o 12.5 Catalent Inc.
o Exhibit 123: Catalent Inc. – Overview
o Exhibit 124: Catalent Inc. – Business segments
o Exhibit 125: Catalent Inc. – Key news
o Exhibit 126: Catalent Inc. – Key offerings
o Exhibit 127: Catalent Inc. – Segment focus
o 12.6 Charles River Laboratories International Inc.
o Exhibit 128: Charles River Laboratories International Inc. – Overview
o Exhibit 129: Charles River Laboratories International Inc. – Business segments
o Exhibit 130: Charles River Laboratories International Inc. – Key news
o Exhibit 131: Charles River Laboratories International Inc. – Key offerings
o Exhibit 132: Charles River Laboratories International Inc. – Segment focus
o 12.7 Coriolis Pharma Research GmbH
o Exhibit 133: Coriolis Pharma Research GmbH – Overview
o Exhibit 134: Coriolis Pharma Research GmbH – Product / Service
o Exhibit 135: Coriolis Pharma Research GmbH – Key offerings
o 12.8 Element Materials Technology Group Ltd.
o Exhibit 136: Element Materials Technology Group Ltd. – Overview
o Exhibit 137: Element Materials Technology Group Ltd. – Product / Service
o Exhibit 138: Element Materials Technology Group Ltd. – Key offerings
o 12.9 Eurofins Scientific SE
o Exhibit 139: Eurofins Scientific SE – Overview
o Exhibit 140: Eurofins Scientific SE – Business segments
o Exhibit 141: Eurofins Scientific SE – Key news
o Exhibit 142: Eurofins Scientific SE – Key offerings
o Exhibit 143: Eurofins Scientific SE – Segment focus
o 12.10 ICON plc
o Exhibit 144: ICON plc – Overview
o Exhibit 145: ICON plc – Product / Service
o Exhibit 146: ICON plc – Key offerings
o 12.11 Intertek Group Plc
o Exhibit 147: Intertek Group Plc – Overview
o Exhibit 148: Intertek Group Plc – Business segments
o Exhibit 149: Intertek Group Plc – Key news
o Exhibit 150: Intertek Group Plc – Key offerings
o Exhibit 151: Intertek Group Plc – Segment focus
o 12.12 Merck KGaA
o Exhibit 152: Merck KGaA – Overview
o Exhibit 153: Merck KGaA – Business segments
o Exhibit 154: Merck KGaA – Key news
o Exhibit 155: Merck KGaA – Key offerings
o Exhibit 156: Merck KGaA – Segment focus
o 12.13 Pace Analytical Services LLC
o Exhibit 157: Pace Analytical Services LLC – Overview
o Exhibit 158: Pace Analytical Services LLC – Product / Service
o Exhibit 159: Pace Analytical Services LLC – Key offerings
o 12.14 SGS SA
o Exhibit 160: SGS SA – Overview
o Exhibit 161: SGS SA – Business segments
o Exhibit 162: SGS SA – Key offerings
o Exhibit 163: SGS SA – Segment focus
o 12.15 Solvias AG
o Exhibit 164: Solvias AG – Overview
o Exhibit 165: Solvias AG – Product / Service
o Exhibit 166: Solvias AG – Key news
o Exhibit 167: Solvias AG – Key offerings
o 12.16 STERIS Plc
o Exhibit 168: STERIS Plc – Overview
o Exhibit 169: STERIS Plc – Business segments
o Exhibit 170: STERIS Plc – Key news
o Exhibit 171: STERIS Plc – Key offerings
o Exhibit 172: STERIS Plc – Segment focus
o 12.17 West Pharmaceutical Services Inc.
o Exhibit 173: West Pharmaceutical Services Inc. – Overview
o Exhibit 174: West Pharmaceutical Services Inc. – Business segments
o Exhibit 175: West Pharmaceutical Services Inc. – Key news
o Exhibit 176: West Pharmaceutical Services Inc. – Key offerings
o Exhibit 177: West Pharmaceutical Services Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations
o Stability and Storage
o growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
o product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Service
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global biopharmaceutical analytical testing services market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Service Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Service – Market share 2022-2027 (%)
Exhibits31: Data Table on Service – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Service
Exhibits33: Data Table on Comparison by Service
Exhibits34: Chart on Bioanalytical – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bioanalytical – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bioanalytical – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bioanalytical – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Method development and validation – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Method development and validation – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Method development and validation – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Method development and validation – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Stability testing – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Stability testing – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Stability testing – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Stability testing – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Service ($ million)
Exhibits51: Chart on End-user – Market share 2022-2027 (%)
Exhibits52: Data Table on End-user – Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by End-user
Exhibits54: Data Table on Comparison by End-user
Exhibits55: Chart on Pharma and biotech companies – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Pharma and biotech companies – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Pharma and biotech companies – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Pharma and biotech companies – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on CROs – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on CROs – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on CROs – Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by End-user ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on APAC – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on APAC – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on South America – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on South America – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on South America – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on South America – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Almac Group Ltd. – Overview
Exhibits117: Almac Group Ltd. – Product / Service
Exhibits118: Almac Group Ltd. – Key offerings
Exhibits119: Boston Analytical – Overview
Exhibits120: Boston Analytical – Product / Service
Exhibits121: Boston Analytical – Key news
Exhibits122: Boston Analytical – Key offerings
Exhibits123: Catalent Inc. – Overview
Exhibits124: Catalent Inc. – Business segments
Exhibits125: Catalent Inc. – Key news
Exhibits126: Catalent Inc. – Key offerings
Exhibits127: Catalent Inc. – Segment focus
Exhibits128: Charles River Laboratories International Inc. – Overview
Exhibits129: Charles River Laboratories International Inc. – Business segments
Exhibits130: Charles River Laboratories International Inc. – Key news
Exhibits131: Charles River Laboratories International Inc. – Key offerings
Exhibits132: Charles River Laboratories International Inc. – Segment focus
Exhibits133: Coriolis Pharma Research GmbH – Overview
Exhibits134: Coriolis Pharma Research GmbH – Product / Service
Exhibits135: Coriolis Pharma Research GmbH – Key offerings
Exhibits136: Element Materials Technology Group Ltd. – Overview
Exhibits137: Element Materials Technology Group Ltd. – Product / Service
Exhibits138: Element Materials Technology Group Ltd. – Key offerings
Exhibits139: Eurofins Scientific SE – Overview
Exhibits140: Eurofins Scientific SE – Business segments
Exhibits141: Eurofins Scientific SE – Key news
Exhibits142: Eurofins Scientific SE – Key offerings
Exhibits143: Eurofins Scientific SE – Segment focus
Exhibits144: ICON plc – Overview
Exhibits145: ICON plc – Product / Service
Exhibits146: ICON plc – Key offerings
Exhibits147: Intertek Group Plc – Overview
Exhibits148: Intertek Group Plc – Business segments
Exhibits149: Intertek Group Plc – Key news
Exhibits150: Intertek Group Plc – Key offerings
Exhibits151: Intertek Group Plc – Segment focus
Exhibits152: Merck KGaA – Overview
Exhibits153: Merck KGaA – Business segments
Exhibits154: Merck KGaA – Key news
Exhibits155: Merck KGaA – Key offerings
Exhibits156: Merck KGaA – Segment focus
Exhibits157: Pace Analytical Services LLC – Overview
Exhibits158: Pace Analytical Services LLC – Product / Service
Exhibits159: Pace Analytical Services LLC – Key offerings
Exhibits160: SGS SA – Overview
Exhibits161: SGS SA – Business segments
Exhibits162: SGS SA – Key offerings
Exhibits163: SGS SA – Segment focus
Exhibits164: Solvias AG – Overview
Exhibits165: Solvias AG – Product / Service
Exhibits166: Solvias AG – Key news
Exhibits167: Solvias AG – Key offerings
Exhibits168: STERIS Plc – Overview
Exhibits169: STERIS Plc – Business segments
Exhibits170: STERIS Plc – Key news
Exhibits171: STERIS Plc – Key offerings
Exhibits172: STERIS Plc – Segment focus
Exhibits173: West Pharmaceutical Services Inc. – Overview
Exhibits174: West Pharmaceutical Services Inc. – Business segments
Exhibits175: West Pharmaceutical Services Inc. – Key news
Exhibits176: West Pharmaceutical Services Inc. – Key offerings
Exhibits177: West Pharmaceutical Services Inc. – Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations
|
| ※본 조사보고서 [세계의 바이오 의약품 분석 시험 서비스 시장 (2023년~2027년)] (코드 : IRTNTR40457-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 바이오 의약품 분석 시험 서비스 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
